Back
Protagonist Therapeutics, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Sell
50
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$83.17
Seasonality Move:
-2.38%
7 Day Trial
ALL ACCESS PASS
$
7
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.Protagonist Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 48.9% based on the past 9 years of stock performance.
-
Protagonist Therapeutics, Inc. has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Protagonist Therapeutics, Inc. Stock Undervalued?The current Protagonist Therapeutics, Inc. [PTGX] share price is $84.79. The Score for PTGX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 48.9% based on the past 9 years of stock performance.
Protagonist Therapeutics, Inc. Stock Rating
Sell
50
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Is Protagonist Therapeutics, Inc. overpriced?
-
Protagonist Therapeutics, Inc. has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Protagonist Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
96.54
52-Week Low:
33.70
Prediction Charts
Market Cap:
5.3B
Price in USD:
84.79
Volume:
609.1K
Beta:
1.94
Technical Analysis
SMA50:
86.40
SMA100:
77.47
SMA200:
64.14
52-Wk Change:
129.91%
Stock Predictions
-
Is Protagonist Therapeutics, Inc. stock public?Yes, Protagonist Therapeutics, Inc. is a publicly traded company.
-
What is the Protagonist Therapeutics, Inc. stock quote today?The Protagonist Therapeutics, Inc. stock price is 84.79 USD today.
-
How to buy Protagonist Therapeutics, Inc. stock online?You can buy Protagonist Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-2 | 86.54 | 87.18 | 88.16 | 85.19 |
| Jan-5 | 87.53 | 84.18 | 87.53 | 82.92 |
| Jan-6 | 83.25 | 82.27 | 85.00 | 81.67 |
| Jan-7 | 82.25 | 82.34 | 82.69 | 79.18 |
| Jan-8 | 81.05 | 80.20 | 82.14 | 79.22 |
| Jan-9 | 80.20 | 80.22 | 81.40 | 79.38 |
| Jan-12 | 79.49 | 80.25 | 81.09 | 78.75 |
| Jan-13 | 79.88 | 81.36 | 82.74 | 79.64 |
| Jan-14 | 80.85 | 85.23 | 85.30 | 80.47 |
| Jan-15 | 84.60 | 84.75 | 87.44 | 84.33 |
| Jan-16 | 84.51 | 81.99 | 84.67 | 81.47 |
| Jan-20 | 81.16 | 83.42 | 83.63 | 79.87 |
| Jan-21 | 82.51 | 83.89 | 83.96 | 80.27 |
| Jan-22 | 82.83 | 84.79 | 85.20 | 80.65 |
Protagonist Therapeutics, Inc. Earnings
Protagonist Therapeutics, Inc. Earnings Report: Per Share Protagonist Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics, Inc. Forecast Revenue Growth
Protagonist Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.93 per share, and a decrease next year of $1.96 per share.
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.